237 related articles for article (PubMed ID: 22285029)
1. Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients.
Touré A; Lauverjat M; Peraldi C; Boncompain-Gerard M; Gelas P; Barnoud D; Chambrier C
Clin Nutr; 2012 Aug; 31(4):567-70. PubMed ID: 22285029
[TBL] [Abstract][Full Text] [Related]
2. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
Chu HP; Brind J; Tomar R; Hill S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
[TBL] [Abstract][Full Text] [Related]
3. Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.
Olthof ED; Rentenaar RJ; Rijs AJ; Wanten GJ
Clin Nutr; 2013 Aug; 32(4):538-42. PubMed ID: 23267744
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
Klek S; Szczepanek K; Hermanowicz A; Galas A
JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
Luther MK; Mermel LA; LaPlante KL
J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
Al-Amin AH; Sarveswaran J; Wood JM; Burke DA; Donnellan CF
J Vasc Access; 2013; 14(4):379-82. PubMed ID: 23817948
[TBL] [Abstract][Full Text] [Related]
9. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
Olthof ED; Versleijen MW; Huisman-de Waal G; Feuth T; Kievit W; Wanten GJ
PLoS One; 2014; 9(11):e111216. PubMed ID: 25379781
[TBL] [Abstract][Full Text] [Related]
10. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
[TBL] [Abstract][Full Text] [Related]
11. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
Demirok A; Illy DHC; Nagelkerke SQ; Lagerweij MF; Benninga MA; Tabbers MM
JPEN J Parenter Enteral Nutr; 2024 May; 48(4):486-494. PubMed ID: 38605559
[TBL] [Abstract][Full Text] [Related]
12. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
[No Abstract] [Full Text] [Related]
14. Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days.
Cotogni P; Pittiruti M; Barbero C; Monge T; Palmo A; Boggio Bertinet D
JPEN J Parenter Enteral Nutr; 2013; 37(3):375-83. PubMed ID: 23002096
[TBL] [Abstract][Full Text] [Related]
15. Ethanol lock therapy in reducing catheter-related bloodstream infections in adult home parenteral nutrition patients: results of a retrospective study.
John BK; Khan MA; Speerhas R; Rhoda K; Hamilton C; Dechicco R; Lopez R; Steiger E; Kirby DF
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):603-10. PubMed ID: 22205580
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
Arnoriaga Rodríguez M; Pérez de Ciriza Cordeu M; Camblor Álvarez M; Bretón Lesmes I; Motilla de la Cámara M; Velasco Gimeno C; Arhip L; García Peris P; Cuerda Compés C
Nutr Hosp; 2018 Jun; 35(4):761-766. PubMed ID: 30070861
[TBL] [Abstract][Full Text] [Related]
17. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections.
Jurewitsch B; Jeejeebhoy KN
Clin Nutr; 2005 Jun; 24(3):462-5. PubMed ID: 15896434
[TBL] [Abstract][Full Text] [Related]
18. Microbiocidal effects of various taurolidine containing catheter lock solutions.
Olthof ED; Nijland R; Gülich AF; Wanten GJ
Clin Nutr; 2015 Apr; 34(2):309-14. PubMed ID: 24861410
[TBL] [Abstract][Full Text] [Related]
19. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
Lambe C; Poisson C; Talbotec C; Goulet O
JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1017-1025. PubMed ID: 29385236
[TBL] [Abstract][Full Text] [Related]
20. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
